3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
31
Neoplasms
8
Neoplasm Metastasis
8
Brain Neoplasms
5
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Glioma
4
Endometrial Neoplasms
4
Triple Negative Breast Neoplasms
3
Neoplasms by Site
3
Breast Diseases
3
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Meningioma
2
Liposarcoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Squamous Cell
1
Neoplasm, Residual
1
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
abemaciclib
×
90 days
×
Clear all
No trials found.